The Hypertrophic Cardiomyopathy: Accelerating Guideline-Driven Care provides participants with the ability to:

• Assess, diagnose, refer and manage the treatment plan of HCM patients based on phenotypes;
• Understand the patient’s journey through this disease, and employ best practices in shared decision-making and referral;
• Incorporate guideline-driven medical care based on the recommendations and the latest “AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines” published in 2024; 
• Adopt guideline-directed medical treatment into the care of your patients with hypertrophic cardiomyopathy.

The faculty consists of expert HCM specialists and scientists from across the world who will guide you through the latest advances in nuclear cardiology, cardiac CT and other imaging modalities.

Table of Contents

1. HCM Pathophysiology in 15 minutes
2. Practical Approaches to HCM Signs and Symptoms
3. Diagnosing HCM:  The Key to A Successful Patient Journey
4. HCM Screening and Genetic Testing: The Who, What and When
5. HCM Shared-Decision Making:  Conversations that Count
6. The HCM Treatment Plan: Contemporary Approaches to Care
7. When to Refer on the HCM Patient Journey
8. HCM Complications: From Heart Failure and Beyond
9. Sudden Cardiac Death: The Reality of Risk
10. HCM Treatment: Myosin Inhibitors
11. Prescribing HCM Treatment:  Expert Insights
12. Final HCM Quiz